TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has provided an announcement.
China Shineway Pharmaceutical Group Limited has announced a forthcoming board meeting scheduled for March 28, 2025, in Hong Kong. The meeting will address the approval of the company’s annual results for the year ending December 31, 2024, and the consideration of a dividend declaration. This announcement is significant for stakeholders as it indicates the company’s ongoing financial activities and potential shareholder returns.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the production and distribution of traditional Chinese medicine products. The company is incorporated in the Cayman Islands and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: -8.08%
Average Trading Volume: 1,015,133
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: HK$6.7B
See more data about 2877 stock on TipRanks’ Stock Analysis page.